Recently, a meta-analysis provided evidence that FGFR2 overexpression is associated with greater depth of tumor invasion, higher rates of lymph node metastasis, more advanced disease stage and worse outcome (Kim et al. 2019). Here, FGFR2 is linked to neoplasm.